HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 479 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2023. The put-call ratio across all filers is 2.95 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,043 | -14.8% | 311,544 | -24.3% | 0.49% | -9.9% |
| Q2 2023 | $42,327 | -5.8% | 411,544 | 0.0% | 0.55% | -11.2% |
| Q1 2023 | $44,916 | -4.1% | 411,544 | 0.0% | 0.62% | -1.0% |
| Q4 2022 | $46,834 | -99.8% | 411,544 | 0.0% | 0.62% | +76.9% |
| Q3 2022 | $25,470,000 | +2.5% | 411,544 | +32.1% | 0.35% | +12.5% |
| Q2 2022 | $24,849,000 | -24.2% | 311,544 | 0.0% | 0.31% | -12.6% |
| Q1 2022 | $32,778,000 | +12.0% | 311,544 | +14.7% | 0.36% | +29.3% |
| Q4 2021 | $29,262,000 | -9.9% | 271,544 | -8.4% | 0.28% | -17.1% |
| Q3 2021 | $32,483,000 | +6.2% | 296,544 | -9.2% | 0.33% | +5.7% |
| Q2 2021 | $30,578,000 | -22.1% | 326,544 | -23.4% | 0.32% | -18.0% |
| Q1 2021 | $39,259,000 | +15.0% | 426,544 | -8.6% | 0.38% | +12.3% |
| Q4 2020 | $34,128,000 | – | 466,544 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |